The results revealed that the serum nesfatin-1 level in NPC patients significantly increased in comparison with that in head and neck tumor patients, rhinitis subjects or healthy donors (Fig. 1C). This evidence concerns the gene NUCB2 and nasopharyngeal carcinoma.